HealthCare

Home > HealthCare
  • All
  • Company Report
  • company reports
  • Industry Report
March 3, 2021

Abbott Laboratories achieved a number of product approvals which include the approval of MitraClip G4, the latest generation of market leading system to repair a leaky mitral heart valve. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis – DCF Analysis – P/E Analysis – Peer Valuation – CrispIdea Forecast Relative […]

Read more
February 26, 2021

The company announced an agreement to acquire Kantar Health for $ 375mn in cash, subject to adjustment. This acquisition is a strong complement to their existing Data as a Service efforts and represents a meaningful entry to the pharmaceutical market. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis – DCF […]

Read more
February 26, 2021

The consolidated revenues for FY20 increased $12.27bn, or 19%, to $77.16bn from $64.89bn inFY19. Total premiums and services revenues rose by 18% from the prior year period. The increase was due to higher premium revenues from Medicare Advantage and state based contracts membership growth. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – Economic Value […]

Read more
February 23, 2021

The company is excited to introduce the first of its kind digital nutrition assistant. Through the use of AI, its Sydney nutrition app will be able to automatically recognize food and log meals in real time, providing users with personalized information and progress on nutrition goals. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – […]

Read more
February 22, 2021

Sanofi and GSK reported interim results of a Phase 1/2 clinical trial to evaluate the safety, reactogenicity (tolerability) and immunogenicity (immune response) of a COVID 19 vaccine candidate . These results demonstrated an insufficient response in older adults and need to refine the concentration of antigen in order to provide high level immune response across […]

Read more
February 17, 2021

NGS orders for the first quarter were $ 17mn, and that is growth of 44% year over year The primary reason for NGS tools revenue growth was the adoption of the product by a larger customer base and a $ 4.6mn shipment to a liquid biopsy customer. Highlights  Valuation – Enterprise Value – CrispIdea Forecast […]

Read more
February 16, 2021

The company advanced their innovative pipeline, sotorasib and Tezepelumaba , both of which have received Breakthrough Therapy Designation from the FDA and it  is ready to launch Sotorasib upon approval and to establish it as a foundational therapy for patients with advanced lung cancer. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added […]

Read more
February 15, 2021

BDX’s expanding innovation pipeline is focused on healthcare’s shifting trends leveraging BD’s core strengths. The company is applying smart devices, robotics & analytics/AI to improve care processes and lower costs. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis – P/E Analysis – Peer Valuation – CrispIdea Forecast Relative to Consensus […]

Read more
February 11, 2021

The company entered into a collaboration with Atalanta Therapeutics. As part of this collaboration, Atalanta will utilize its proprietary branched siRNA platform to develop potential treatments for multiple CMS targets, including HTT for the treatment of Huntington’s disease. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis – P/E Analysis – […]

Read more
February 10, 2021

Change Healthcare brings widely adopted technology for integrating evidence based clinical criteria directly into the clinician’s workflow, while Optum’s clinical analytics expertise and Individual Health Record can strengthen the evidence base needed to deliver effective clinical decision support at the point of care. Highlights Valuation –Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis […]

Read more
February 3, 2021

In 2020, the company continued to advance transformative innovation for patients, including treatments for hyperlipidemia and multiple sclerosis. It received 26 approvals for new treatments as well as new indications for existing treatments in the US, the EU, Japan and China. Highlights  Valuation – Enterprise Value – CrispIdea Forecast – P/E Analysis – Peer Valuation – […]

Read more
January 29, 2021

Merck & Co Inc is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Pfizer Inc is a research-based global biopharmaceutical company and is engaged in the discovery, development and manufacturing of healthcare products and its portfolio includes medicines and vaccines. In relation […]

Read more
January 18, 2021

HMS continue to innovate, and are regularly adding new and enhanced solutions to their comprehensive business lines. A key component of strategic growth plan is to gain a greater foothold in the Medicare Advantage market, which will continue to be the fastest growing segment of the healthcare market. Executive Summary Financial Statements – Income Statement […]

Read more
January 12, 2021

U.S. Medical Segment adjusted revenues increased by 5% to $9.63bn in Q3FY20 which reflects customer growth in U.S. Commercial insured and Medicare Advantage businesses, as well as higher premium rates due to anticipated underlying medical cost trend and the resumption of the health insurance industry tax. Executive Summary Financial Statements – Income Statement and Forecast […]

Read more
January 11, 2021

Agilent’s Life Sciences and Applied Markets Group (LSAG) grew a reported 8% year over year to $671mn. The revenue performance reflected generally improving conditions across geographies led by growth in the Food, Pharma, and C&E markets, and highlighted by strength in Cell Analysis and Mass Spectrometry. Executive Summary Financial Statements – Income Statement and Forecast […]

Read more
January 6, 2021

BD Life Sciences segment, revenues for the quarter of $1.488bn increased 31.2% over the prior-year period. The segment’s results were driven by strong sales related to COVID-19 diagnostic testing solutions in the Diagnostic Systems unit on the BD VeritorTM and BD MaxTM platforms. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet […]

Read more
December 29, 2020

The company acquired an exclusive license for myopia control contact lenses designed by BHVI. Myopia is a leading cause of visual impairment in children and the company plan to pair this novel contact lens design with their contact lens technology to develop potential treatments to slow the progression of myopia in children. Executive Summary Financial […]

Read more
December 24, 2020

Humana, in partnership with CMS, was among the first in the industry to quickly implement benefit changes for Medicare Advantage members that removed financial barriers, improved access to care, and address social determinants of health needs during the pandemic. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
December 22, 2020

Pfizer announced that the Phase 3 CROWN study of lorlatinib in people with previously untreated advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer met its primary endpoint  by demonstrating significantly improved progression-free survival, as compared to Xalkori (crizotinib). Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q3FY20 […]

Read more
December 17, 2020

The company progressed well in newer areas, including Data Cloud, MyVeeva for Doctors, and Veeva Link. It expect these products will set us up for a long runway of growth in commercial. The company think the customers can generate meaningful productivity gains over the coming years as they increasingly leverage digital platforms. Executive Summary Financial […]

Read more
December 15, 2020

MRK laboratories made important advances in new product opportunities and development. As an example, during the third quarter, the United States FDA approved an expanded label for KEYTRUDA in the setting of relapsed or refractory classical Hodgkin lymphoma based on KEYNOTE-204 study that compared KEYTRUDA monotherapy to treatment with brentuximab vedotin, a standard therapy. Executive […]

Read more
December 15, 2020

HIV product sales increased by 8% to $4.5bn for Q3FY20 due to core HIV business driven by higher volume as channel inventory continues to normalize in the United States following the second quarter consumption of the stockpiling from Q1FY20, as well as stronger patient demand, including the continued patient uptake of Biktarvy and growth of […]

Read more
December 9, 2020

Allscripts invested in Software development as a part of innovation strategy. This has been demonstrated by the success of the patent program, where they recently issued 5 patents over the course of 8 days. Some examples include higher patient engagement and adherence to patient’s goal tracking by connecting to compay’s EHRs and various wellness applications. […]

Read more
December 4, 2020

The company completed the divestitures of noncore assets in Germany and Spain, as well as the remainder of commercial RevWorks services business. Revenue in Q3 related to the sale of the commercial RevWorks business was impacted more than expected. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
December 4, 2020

Entresto saw excellent performance quarter with 45% growth in sales driven by underlying strong demand across geographies. Entresto is recognized as standard of care for treatment of HFrEF and delivers on its value proposition of keeping patients out hospital. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
December 3, 2020

TRHC acquired Personica in early October. It is excited to add Personica’s pharmacy services that provides with more than 27,000 new PACE members to this TRHC CareVention HealthCare family. With 1 of the 5 PACE-focused CareVention services, the company now touch more than 90% of all PACE organizations. Executive Summary Financial Statements – Income Statement […]

Read more
November 26, 2020

AMGN’s Biosimilar revenues were $480mn supported by share growth by MVASI and KANJINTI. The company achieved leading biosimilar shares for AMGEVITA in Europe and for MVASI and KANJINTI in the US.The company experienced positive Phase 2 results of firstin- class molecule sotorasib and it expect to see top line Phase 3 data for tezepelumab, a […]

Read more
November 20, 2020

Digital platforms have long been an area of focus even prior to the pandemic and this year the company expect to gain a significant percentage of sales through digital channels. The development of Medicare care guide is just one way the company is enhancing members on-boarding experience with proactive outreach to help them understand their […]

Read more
November 10, 2020

UnitedHealth Group  is advancing modern telehealth as a part of overall strategy to build high- performing systems of care. These growing therapeutics capacities are positively impacting the management of chronic diseases. The company is planning to invest in more digital therapeutics in the coming months and years. Executive Summary Financial Statements – Income Statement and […]

Read more
November 6, 2020

The company launched innovative Thermo Scientific products across businesses, highlighted by two Selectris imaging filters for cryo-electron microscopes that accelerate research in structural analysis of proteins, and the POROS Oligo (dT)25 Affinity Resin to advance mRNA-based therapies and vaccines. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
November 6, 2020

Johnson & Johnson  announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. (“Momenta”), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q3FY20 Results Overview – […]

Read more
October 31, 2020

Veeva took steps to improve their digital engagement strategy. Veeva Approved Email and Veeva Engage Meeting usage increased, and virtual events business in the Physicians World gained momentum. The company worked on product innovation and support programs like free Engage Meetings, which they extended through the end of the year. In the data area, there […]

Read more
October 31, 2020

The company continue to invest in portfolio across all businesses. The launching include two new LC-Mass-Spec products — the Agilent 6470B Triple Quad and the Agilent Rapid Fire 400 system. Both products are aimed at high -throughput labs, driving productivity and superior resolution. It also launched CrossLab Asset Monitoring service, which is a new subscription […]

Read more
October 31, 2020

HMS Holdings Corp continued to invest in technology to drive efficiency which include robotic process automation, machine learning, AI. It is expected that these synergies will continue to accrue in the back half of the year, but definitely the more majority of it is going to be revenue driven. Executive Summary Financial Statements – Income […]

Read more
October 31, 2020

The company have decided to spin-off its eye health business as an independent publicly traded company. This spin-off will establish two separate companies, a eye health company built on the iconic Bausch Health brand and an international diversified pharmaceutical company with leading physicians  in gastroenterology, dermatology, aesthetics, neurology and an international pharma business. Executive Summary […]

Read more
October 28, 2020

Twist experienced significant progress for biopharma vertical with first top 10 pharma partnership. There are several other companies which are embracing the antibody discovery platform and company is exploring partnerships with them.The growth in revenue was the result of strong Synthetic Biology and NGS sales as well as initial revenue from biopharma partnerships. Executive Summary […]

Read more
October 15, 2020

Allscripts dbMotion™ Solution has been delivering clinically relevant, meaningful interoperability for many years. With dbMotion, which enables the sharing of data across different EHR systems regardless of vendor, clinicians can engage their care teams and improve access to real-time, harmonized information from across the care continuum. Executive Summary Financial Statements – Income Statement and Forecast […]

Read more
October 15, 2020

Humana made significant investments in Medicare distribution channels, equipping and training brokers so that they can interact with consumers telephonically and digitally in circumstances where community events and face-to-face engagements are restricted given the pandemic. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q2FY20 Results – Overview […]

Read more
October 12, 2020

The company launched MedWise within PrescribeWellness community pharmacy network which enables pharmacists to simulate changes to a patient’s medication regimen and visually see the impact on the medication risk score in real time. This new feature tremendously helps to assess simultaneous accumulative multidrug interactions amongst complex medication regimens in an efficient manner. Executive Summary Financial […]

Read more
October 9, 2020

Becton, Dickinson and Co launched four new products in the quarter and remain on track to deliver robust innovation pipeline for the year. It launched an upgrade to the BD FACS Melody to expand from 2-way sorting to 4-way sorting, enabling customers to capture more cell types. Executive Summary Financial Statements – Income Statement and […]

Read more
October 7, 2020

LiveHealth Online, Anthem’s on-demand telehealth solution, surpassed 1mn visits in early April, and demand continues. Demand for telemedicine in the behavioral health space is also increasing with usage of 56 times pre-COVID levels. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q2FY20 Results – Overview – 1HFY20 […]

Read more
October 5, 2020

In oncology, KEYTRUDA sales grew 31% year-over-year, reaching $3.4bn in the quarter. In the U.S., KEYTRUDA demonstrated strong growth across all key tumor types. It received FDA approval for a 6-week dosing regimen across all adult indications, which enabled greater patient access and contributed to growth. Executive Summary Financial Statements – Income Statement and Forecast […]

Read more
September 28, 2020

Biopharma revenues increased by 4% to $9.8bn in Q2FY20. driven by strong performances from many of key growth drivers, including VYNDAQEL/VYNDAMAX, Eliquis, IBRANCE, Inlyta, XTANDI and biosimilars portfolio. The Oncology business was strong, up 20% operationally compared with the year ago quarter. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – […]

Read more
September 28, 2020

Gilead Sciences completed the acquisition of Forty Seven for $4.9bn that it had announced during Q1. This brings magrolimab into their core pipeline as an investigating compound which is currently being developed for MDS and AML. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q1FY20 Results – […]

Read more
September 23, 2020

The company is confident in the long-term growth potential of innovative medicines like Otezla, Repatha, Prolia, EVENITY, and Aimovig as well as expanding portfolio of marketed biosimilars .Otezla sales was $561mn in Q2FY20. It was acquired in November 2019 and generated 14% growth year-over-year driven primarily by volume. Executive Summary Financial Statements – Income Statement […]

Read more
September 21, 2020

Novartis is looking for expansion with significant Phase 3 pivotal studies of canakinumab and ruxolitinib, as well as 35 investigator-initiated trials covering over 20 Novartis medicines currently in the clinic.The company expects Innovative Medicines to grow mid single digit and Sandoz to grow low single digit in FY20. Executive Summary Financial Statements – Income Statement […]

Read more
September 17, 2020

Health Services revenue increased by 2.2% to $28.6bn in Q2FY20 due to the insourcing of Integrated Medical pharmacy volumes and strong organic growth, including continued growth in specialty pharmacy services, partially offset by reduced retail script volumes due to the COVID-19 pandemic. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – […]

Read more
September 11, 2020

For years, financial challenges have shadowed the world’s public and private health systems to varying degrees, and experts expect the situation to persist in 2020. This will make “value” a watchword in health care payment reform. The entry of non-traditional players in the health care sector have the potential to both support and suppress incumbent […]

Read more
September 7, 2020

Principia’s Bruton tyrosine kinase (BTK) inhibitors add to Sanofi’s efforts to accelerate and build a portfolio of the next generation of transformative treatments for autoimmune diseases. BTK is present in the signaling pathways of key innate and adaptive cell types of the immune system. Being able to block or disrupt these signaling processes can help […]

Read more
September 7, 2020

Sanofi’s country launch program has 89 planned launches in FY20 which are on track. Its U.S. launch in pediatric atopic dermatitis is off to a strong start with already over 500 unique prescribers for Dupixent. It achieved an important regulatory milestone in the quarter, both for Sanofi China strategy and for the Dupixent franchise with […]

Read more
September 2, 2020

Pharmaceutical sales of $10.8bn grew 3.9%, enabled by growth across all regions and in all key therapeutic areas, except for the cardiovascular, metabolism and other therapeutic area, due primarily to biosimilar competition on PROCRIT. The company realized double digit growth in eight key products. The growth in the quarter was negatively impacted by COVID -19. […]

Read more
August 27, 2020

Access to primary and preventative health care is critical to improving and maintaining health. In Florida, the challenge is compounded by a shortage of health care providers — especially in low-income urban and rural communities. To address these critical needs, the United Health Foundation has committed $1.7 million to improve access to primary care in […]

Read more
August 11, 2020

Veeva Data Cloud is powered by the Crossix data platform, which gives company a distinct advantage. Customer feedback on Data Cloud has been very positive, and the company have already signed their first two early adopters for pilots, one emerging biotech and one top-20 pharma. Executive Summary Financial Statements – Income Statement and Forecast – […]

Read more
August 10, 2020

Siemens Healthineers, a Siemens AG subsidiary, and Varian Medical Systems Inc. a leader in the field of cancer care, have been working together in the strategic “Envision” partnership to shape the future of cancer treatment and research. Varian’s specialized offerings, including the intelligent cancer care approach and ongoing efforts in artificial intelligence, machine learning and […]

Read more
August 5, 2020

Tabula Rasa HealthCare® Corporation, a healthcare technology company advancing the field of medication safety has partnered with Equiscript, a 340B patient pharmacy care and technology company, to deliver advanced medication adherence reports and analytics for Equiscript and its community health center and hospital clients. Executive Summary Financial Statements – Income Statement and Forecast – Balance […]

Read more
August 4, 2020

Agilent Technologies Inc. announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge, Massachusetts. LabCentral is a shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups. The Golden Ticket provides funding of one lab bench space for […]

Read more
July 31, 2020

Becton, Dickinson and Company completed the acquisition of Straub Medical, which will further expands the company’s portfolio with a proven device with that’s approved with dual indications for arterial atherectomy and thrombectomy in the U.S. It has solid existing sales in Europe and China. The company is leveraging their strong existing channel and expertise in […]

Read more
July 31, 2020

Twist Bioscience  introduced a Targeted Methylation Sequencing solution, in February 2020. This product is ideal for customers, focused on liquid biopsy, as it can be used to study methylation pattern changes in a wide range of research fields. The company is working with initial customers and believe it would represent an important area accruals for […]

Read more
July 28, 2020

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (“Bausch Health”), announced the European launch of the company’s first Extended Depth of Focus intraocular lens (IOL), LuxSmart™, and a new monofocal IOL, LuxGood™. Both feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology. Executive Summary Financial Statements – Income […]

Read more
July 27, 2020

Allscripts and Microsoft Corp. announced the extension of their long-standing strategic alliance to enable the expanded development and delivery of cloud-based health IT solutions. The five-year extension will support company’s cloud-based Sunrise™ electronic health record, making Microsoft the cloud provider for the solution and opening up co-innovation opportunities to help transform healthcare with smarter, more […]

Read more
July 23, 2020

Pfizer and the German biotech company, BioNTech, has entered into a global collaboration agreement to co-develop the potential first-in-class mRNA-based coronavirus vaccine program aimed at preventing COVID-19 infection. It received regulatory approval from German authority Paul-Ehrlich- Institut to commence the first clinical trial for COVID-19 vaccine candidates in Germany, and the first patient has already […]

Read more
July 21, 2020

AbbVie and Genmab will work together on three prospective antibody products, as well as potential antibody cancer therapies. AbbVie paid $750mn to Genmab right out of the gate, with additional instalments of up to $3.15bn to follow. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q1FY20 – […]

Read more
July 21, 2020

Merck announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation therapies for infectious diseases and cancer. The U.S. Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the company has received merger control clearance from the Austrian […]

Read more
July 13, 2020

Humana Inc. has been selected by the Kentucky Cabinet for Health and Family Services (CHFS) to continue serving children and adults across the health company’s home state of Kentucky through the Department for Medicaid Services. Humana currently provides coordinated medical, wellness, and pharmacy benefits coverage and services to 150,000 Kentucky Medicaid recipients. The new contract […]

Read more
July 10, 2020

Gilead entered into several additional agreements to advance its business, including a four-year strategic collaboration with Second Genome, Inc. to identify biomarkers associated with clinical response in up to five of Gilead’s pipeline compounds in inflammation, fibrosis and other diseases, and to identify potential new targets and drug candidates for the treatment of inflammatory bowel […]

Read more
July 8, 2020

Amgen continued integration of Otezla® and successfully completed integration of the Astellas partnership in Japan. The company  continued to progress the collaboration with BeiGene in China. This has led the company to expand its global footprint. It also has been working closely with collaborators at  AstraZeneca and Cytokinetics on the execution of the pivotal studies […]

Read more
June 29, 2020

The combination with Express Scripts, has positioned the company to deliver exceptional value for the benefit of the customers, patients and clients. Further the partnership with MDLive and Buoy Health, allows Cigna to became the first partner to offer virtual care for annual checkups.Business segments like Health Services, Integrated Medical and International, performed at or […]

Read more
June 25, 2020

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least […]

Read more
June 19, 2020

Anthem, Inc. announced the completion of its acquisition of Beacon Health Options (Beacon), the largest independently held behavioral health organization in the country serving more than 36 million people across all 50 states. The acquisition offers Anthem the opportunity to combine its current behavioral health capabilities with Beacon’s successful model and support services in order […]

Read more
June 15, 2020

UnitedHealth Group will provide more than $1.5 billion in initial assistance, including customer premium credits, to its UnitedHealthcare customers as many people have been unable to access routine or planned care due to the COVID-19 pandemic. Consequently, UnitedHealthcare has seen a lower volume of medical care being delivered than was anticipated when pricing was initially […]

Read more
June 10, 2020

TMO’s largest end markets segment, Pharma and biotech, was essentially unaffected by the pandemic in Q1. It had strong performance in bioproduction and pharma services businesses. In diagnostics and healthcare, the company grew in the low double digits. There was a rapid uptake of their diagnostic kits, which leveraged their assays and real-time PCR instruments […]

Read more
June 5, 2020

As part of its safety surveillance program, Novartis has been actively evaluating post-marketing cases reported as severe vision loss, retinal artery occlusion and/or vasculitis with Beovu® (brolucizumab). The company have been working closely with the reporting physicians and retina specialists to get their perspective and collect the relevant clinical and imaging data in a manner […]

Read more
June 2, 2020

Cerner Corporation, a global health care technology company, and Intermountain Healthcare, an integrated, not-for-profit health system serving the western U.S., announced a multiyear expansion of the two organizations’ longstanding commitment to improve the safety, quality and experience of health care for patients and caregivers. For years, Intermountain has been one of Cerner’s most closely ligned […]

Read more
May 26, 2020

Veeva Systems announced an increasing number of life sciences companies are adopting applications in the Veeva Vault RIM Suite to streamline regulatory information management. More than 200 companies are now using Vault RIM applications to modernize their regulatory business operations for faster submission development and better visibility across processes for improved compliance. Executive Summary Financial […]

Read more
May 22, 2020

Sanofi and Regeneron Pharmaceuticals, Inc.announced the primary endpoint of overall survival (OS) was met in a Phase 3 trial comparing the PD-1 inhibitor Libtayo® (cemiplimab) to platinum doublet chemotherapy in patients with first-line locally advanced or metastatic non-small cell lung cancer (NSCLC) that tested positive for PD-L1 in ≥50% of tumor cells. Based on a […]

Read more
May 22, 2020

The demand for healthcare IT is majorly driven by continuous technological advancements for providing improved healthcare facilities, increased government support & spending on healthcare IT solutions, and rising need to manage individual health data at a single platform . Moreover, need of decreasing healthcare cost by increasing adoption of healthcare IT systems would also influence […]

Read more
May 21, 2020

Medtronic plc announced its Medtronic Care Management Services (MCMS) business is launching two new solutions designed to help assess, monitor, and triage support for patients who may be concerned about COVID-19 and their respiratory symptoms. It has already launched its new Respiratory Infectious Disease Health Check to existing MCMS customers, and it is now launching […]

Read more
May 15, 2020

Agilent Technologies announced that it is joining forces with the Indian Institute of Technology Delhi (IIT Delhi) to promote biopharmaceutical research. Agilent and IIT Delhi signed a memorandum of understanding under which, Agilent, a leader in the biopharma space, is contributing funds to support the incubator at IIT New Delhi to support researchers at the […]

Read more
May 4, 2020

TWST signed a collaboration with Schrödinger, Inc. a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ technology platforms together to discover new antibody therapeutics against G-protein coupled receptor (GPCR) targets.  Executive Summary  Financial Statements – Income Statement and Forecast – Balance Sheet – Cash […]

Read more
April 28, 2020

Gilead Sciences and Forty Seven, Inc. announced in March 2020, that the companies have entered into a definitive agreement pursuant to which the company  will acquire Forty Seven for $95.50 per share in cash. The transaction values Forty Seven at ~$4.9bn. Through the acquisition Forty Seven’s investigational lead product candidate, magrolimab will strengthen Gilead’s immuno-oncology […]

Read more
April 28, 2020

Amgen announced strategic collaborations with leading diagnostic companies Guardant Health, Inc. and QIAGEN N.V. to develop blood- and tissue-based companion diagnostics (CDx), respectively, for investigational cancer treatment AMG 510. AMG 510 is the first KRASG12C inhibitor to advance to the clinic for investigation in treatment of multiple tumor types. KRAS G12C is one of the […]

Read more
April 28, 2020

Merck announced its Intention to focus on Key Growth Pillars through spinoff of Women’s Health, trusted Legacy Brands and biosimilar Products into NewCo. Merck expected to receive $8B to $9B through special tax-free dividend from NewCo upon transaction closing. The spinoff is expected to be completed in 1HFY20. Executive Summary  Financial Statements – Income Statement […]

Read more
April 27, 2020

Humana announced a strategic partnership with Welsh, Carson, Anderson & Stowe that will accelerate payeragnostic center expansion giving more seniors access to quality primary care built around their unique health needs, especially in geographies that lack the access today. Executive Summary  Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
April 23, 2020

DHR continued to evolve into a higher growth company as they announced the GE Biopharma acquisition and completed the IPO and subsequent split-off of its dental segment into an independent publicly traded company called Envista. Executive Summary  Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Q4FY19 Results– Overview – […]

Read more
April 17, 2020

Pfizer expects continued strong growth from certain in-line brands such as Ibrance, Eliquis, Xeljanz, Xtandi and Inlyta, from recent and expected product launches such as Vyndaqel/Vyndamax, Braftovi, Mektovi and oncology biosimilars as well as from emerging markets.The company  also announced a definitive agreement to combine Upjohn and Mylan to create a new global pharmaceutical company, […]

Read more
April 14, 2020

Cigna organically grew global medical customer base to 17.1mn lives. In 2019, The company  once again delivered double digit organic customer growth in Select segment with continued enrollment gains in middle market. The results drove strong financial performance in 2019 and provided the company with considerable momentum as they step into 2020 with outstanding strategic […]

Read more
April 6, 2020

Cerner Corporation, a global health care technology company, recognizes Cornwall Community Hospital (CCH) for receiving Canada’s highest level of accreditation through Accreditation Canada’s Qmentum International Accreditation Program. The accreditation program is designed to focus on quality and safety throughout all aspects of an organization’s services, from leadership to direct care. Executive Summary  Financial Statements – […]

Read more
March 17, 2020

Abbott and Insulet Corporation , the global leader in tubeless insulin pump technology with its  mnipod® Insulin Management System (Omnipod System), announced today they are partnering to integrate Abbott’s world-leading1 glucose sensing technology with Insulet’s next-generation tubeless system, the Omnipod Horizon™ Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery […]

Read more
March 16, 2020

J&J has strong pipeline of products which will continue to deliver growing sales to keep revenue from its pharmaceuticals segment afloat. Some of the company’s current products are also seeking additional indications. Imbruvica is currently in phase 3 testing for the treatment of mantle cell lymphoma, and Tremfya is in phase 3 testing for the […]

Read more
March 16, 2020

TMO  significantly strengthened its pharma services network in 2019 by acquiring leading viral vector manufacturer Brammer Bio and the GSK active pharmaceutical ingredient manufacturing site in Ireland and expanding production capacity at facilities in North America and Europe to support growing demand for biologics and gene therapies.  Executive Summary Financial Statements – Income Statement and […]

Read more
March 4, 2020

Novartis’s key growth drivers were mainly Cosentyx,Entresto and Zolgensma for the Pharmaceuticals Business Unit and Promacta/Revolade, Kisqali and Lutathera for the Oncology Business Unit.The company acquired “The Medicines Company”, adding inclisiran a potentially transformative cholesterol-lowering therapy. NVS also acquired Xiidra, strengthening ophthalmic pharmaceuticals portfolio. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet […]

Read more
February 27, 2020

Anthem successfully completed the IngenioRx migration, transitioning more than 15mn people over the past 8 months. The launch of IngenioRx is a key milestone for the growth of the company as they expect huge revenues growth in coming quarters. Executive Summary  Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
February 25, 2020

Biogen recently won a patent challenge to its billion-dollar MS drug, Tecfidera. Unless an appeal by Mylan or other ongoing patent challenges results in a different ruling, this means that the company can stave off Tecfidera competition until patent expiration in 2028. It presented detailed results from the Phase 3 EVOLVE-MS-2 study of VUMERITY (diroximel […]

Read more
February 24, 2020

UnitedHealthcare Medicare & Retirement revenues grew by 10.3% to $83.3bn in 2019, as the business grew to serve 5.3mn people in Medicare Advantage at year end, an increase of 325,000 in 2019. Medicare Advantage growth was diversified, reflecting strong performance in both the individual and group retiree markets. • Executive Summary • Financial Statements – […]

Read more
February 14, 2020

BHC delivered another strong quarter with both reported and organic revenue growth due to growth in its segments. In addition to organic revenue growth in both the Bausch +Lomb/International and Salix segments, due to higher revenues in several of durable, established brands, such as XIFAXAN®, BioTrue® ONEday and Bausch + Lomb ULTRA®, performance was also […]

Read more
December 2, 2019

The U.S. economy grew by 1.9% in Q3FY19. There was a dip in net exports, private, fixed investments and inventories which weighed on the growth, but the consumer spending stabilized the American economy. The consumer confidence plummeted in August, post the fresh escalations to the U.S.- China trade war. There was a contraction in the […]

Read more
November 28, 2019

Impact investing is an exciting and rapidly growing industry powered by investors who are determined to generate social and environmental impact as well as financial returns. This is taking place all over the world, and across all asset classes. Table of Contents Executive Summary Overview Industry Analysis Result Based Financing Green Bonds Trends in 2019 […]

Read more
August 16, 2019

Total revenues for the quarter increased by 8% to $1.39bn. This increase was due to ongoing demand from new and existing clients. Bookings decreased by 11% to $1.24bn due to decline in long term contracts. Operating cash flow were $317mn in Q1FY19. Free cash flow decreased by $132mn due to decrease in cash from operations […]

Read more
August 7, 2019

Anthem reported significant growth in the risk-based membership and improved the penetration of the clinical and specialty services. The operating revenues increased by $2,129mn to $24,666mn in Q1FY19 compared to $22,537mn in Q1FY18. The increase in operating revenues was due to membership growth and rate increases. Number of Slides – 38 Contents Executive Summary Financial […]

Read more
July 29, 2019

Worldwide sales for Merck increased by 8% to $10.8bn in Q1FY19, excluding the negative impact from foreign exchange, sales grew 11%, driven by growth in Oncology and Vaccines. GAAP EPS were $1.12 for the quarter and non-GAAP EPS increased by 16% to $1.22 for the quarter. Number of Pages – 43 Contents Executive Summary Financial […]

Read more
June 27, 2019

Pfizer’s revenues increased by 1.6% to $13.1bn in Q1FY19, which reflects operational growth of 5% and the unfavorable impact of foreign exchange of 4%. GAAP EPS increased by 15% to $0.68 in Q1FY19. Number of Pages – 56 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q1FY19 Results – Overview […]

Read more
June 14, 2019

Novartis revenues grew by 2% to $11.1bn in Q1FY19 with the Mayzent launch, successful Alcon spin-off, and strong operational execution. Core operating income grew at 18% and core margin expanding by 2.6% during the quarter. Net income grew by 4% due to the impact of a net impairment charge and lower divestment gains. Number of […]

Read more
June 11, 2019

Bausch Health is off to a strong start in 2019 with the continued growth of XIFAXAN® which grew 11% in the quarter, the launch of BRYHALI™, the successful acquisition of TRULANCE®, and the approval of DUOBRII™ and expected a launch in June. Number of Pages – 47 Contents Executive Summary Financial Statements –Income Statement and […]

Read more
June 11, 2019

UnitedHealth Group’s revenues grew by 9.3% to $60.3bn in Q1FY19 led by UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth. Number of Pages – 39 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q1FY19 Results – Overview –Q1FY19 – Segment Performance –FY19 – Guidance and Conclusion –GAAP to Non-GAAP Reconciliation Historical […]

Read more
June 11, 2019

JNJ’s sales grew by 0.1% to $20bn in Q1FY19 with 3.9% operational growth and 5.5% adjusted operational sales growth. Adjusted EPS increased by 1.9% to $2.1 and GAAP EPS decreased by 13.1% to $1.39 Number of Pages – 54 Contents: Executive Summary Financial Statements –  Income Statement and Forecast –  Balance Sheet –  Cash Flow […]

Read more
March 11, 2019

Global Healthcare IT Market is expected to grow to USD 340.9 Bn in 2024, from USD 131bn in 2016 and, growing at a CAGR of 12.5% during the forecast period 2017 to 2024.

Read more
Load more